hydrazine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, S; Bhat, S; Byrd, JC; Canfield, D; Cempre, CB; Fu, Q; Hu, B; Huang, Y; Jaglowski, SM; Lapalombella, R; Lockman, H; Rogers, KA; Ruppert, AS; Shah, H; Stephens, DM; Vadeboncoeur, R; Walker, JS; Woyach, JA | 1 |
| Blunt, MD; Cragg, MS; Del Rio, L; Doyle, ADP; Fisher, JG; Forconi, F; Graham, LV; Henderson, I; Johnson, PWM; Khakoo, SI; Landesman, Y; Sale, B; Sonar, S; Walker, CJ | 1 |
| Arruga, F; Boccellato, E; Bruno, B; Coscia, M; Deaglio, S; Efremov, DG; Griggio, V; Jones, R; Landesman, Y; Perutelli, F; Riganti, C; Todaro, M; Vaisitti, T; Vitale, C | 1 |
| Algrin, C; Bougacha, N; Brunelle-Navas, MN; Chapiro, E; Choquet, S; Cosson, A; Cung, HA; Damm, F; Davi, F; Feugier, P; Gabillaud, C; Herbi, L; Keren, B; Lambert, J; Landesman, Y; Le Garff-Tavernier, M; Leblond, V; Lejeune, J; Lepretre, S; Lesty, C; Maloum, K; Merle-Béral, H; Morel, V; Nguyen-Khac, F; Roos-Weil, D; Susin, SA; Sutton, L; Uzunov, M | 1 |
| Burger, J; Ferrajoli, A; Jain, N; Keating, M; O'Brien, S; Paul, S; Wierda, W | 1 |
| Baldacci, E; Canichella, M; Chistolini, A; Di Rocco, A; Ferretti, A; Foà, R; Gabriella Mazzucconi, M; Martelli, M; Miulli, E; Pulsoni, A; Santoro, C; Serrao, A | 1 |
| Andritsos, LA; Beckwith, KA; Byrd, JC; Dubovsky, JA; El-Gamal, D; Flynn, JM; Goettl, VM; Harrington, BK; Jha, S; Jones, JA; Kauffman, M; Lapalombella, R; Maddocks, KJ; McCauley, D; Mo, X; Shacham, S; Williams, KE; Zhong, Y | 1 |
| Jolliffe, E; Romeril, K | 1 |
| Chang, H; Shih, LY | 1 |
| Beckwith, KA; Byrd, JC; Guinn, D; Hing, ZA; Johnson, AJ; Lapalombella, R; Lehman, AM; Mantel, R; Smith, LL; Williams, E; Williams, K; Woyach, JA | 1 |
| Birgens, H; Brown, Pde N; Dalseg, AM; Dufva, IH; Hasselbalch, HC; Jensen, MK; Vangsted, A | 1 |
| Keating, MJ; Koehrer, S; Wierda, WG | 1 |
| Frederiksen, H; Gudbrandsdottir, S; Hasselbalch, H | 1 |
| Bahler, DW; Preobrazhensky, SN | 1 |
1 review(s) available for hydrazine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
[Novel medical treatment modalities in hematology].
Topics: Aminoglycosides; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Benzoates; Boronic Acids; Bortezomib; Carbazoles; Carrier Proteins; Cyclophosphamide; Dasatinib; Furans; Gemtuzumab; Hematologic Diseases; Humans; Hydrazines; Imatinib Mesylate; Immunologic Factors; Indoles; Lenalidomide; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Piperazines; Purpura, Thrombocytopenic; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thalidomide; Thiazoles; Thrombopoietin; Vidarabine | 2008 |
2 trial(s) available for hydrazine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
Topics: Adenine; Adult; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Piperidines; Pyrazoles; Pyrimidines; Triazoles | 2022 |
A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.
Topics: Aged; Aged, 80 and over; Benzoates; Female; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pyrazoles; Thrombocytopenia | 2019 |
11 other study(ies) available for hydrazine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.
Topics: Exportin 1 Protein; Histocompatibility Antigens Class I; HLA-E Antigens; Humans; Hydrazines; Karyopherins; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Receptors, Cytoplasmic and Nuclear | 2023 |
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Combinations; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Mice | 2023 |
Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1.
Topics: Apoptosis; Chromosomes, Human, Pair 2; Drug Resistance, Neoplasm; Exportin 1 Protein; Gene Expression Regulation, Leukemic; Humans; Hydrazines; Karyopherins; Leukemia, Lymphocytic, Chronic, B-Cell; Receptors, Cytoplasmic and Nuclear; Triazoles | 2017 |
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma.
Topics: Adult; Aged; Benzoates; Female; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasm Proteins; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombopoietin | 2019 |
Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.
Topics: B-Lymphocytes; Cell Movement; Cell Proliferation; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Triazoles | 2014 |
Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.
Topics: Benzoates; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles | 2014 |
Chronic lymphocytic leukemia-associated refractory immune thrombocytopenia successfully treated with eltrombopag.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Murine-Derived; Benzoates; Hemorrhage; Humans; Hydrazines; Immunoglobulins; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases; Male; Platelet Count; Platelet Transfusion; Pyrazoles; Rituximab; Thrombocytopenia | 2015 |
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Piperidines; Pyrazoles; Pyrimidines; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Drug Resistance, Neoplasm; Female; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Salvage Therapy | 2010 |
Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Benzoates; Blood Platelets; Celiac Disease; Denmark; Female; HIV Infections; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Male; Middle Aged; Off-Label Use; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recurrence; Retrospective Studies; Thrombocytopenia; Thrombopoietin | 2012 |
Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia.
Topics: Antibodies; Antibody Specificity; B-Lymphocytes; Binding, Competitive; Biomarkers; Cell Survival; Flow Cytometry; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Predictive Value of Tests; Reproducibility of Results; ZAP-70 Protein-Tyrosine Kinase | 2008 |